A detailed history of Nantahala Capital Management, LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 600,000 shares of ELDN stock, worth $3.18 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
600,000
Previous 600,000 -0.0%
Holding current value
$3.18 Million
Previous $1.58 Million -0.0%
% of portfolio
0.11%
Previous 0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.57 - $3.12 $942,000 - $1.87 Million
600,000 New
600,000 $1.58 Million

Others Institutions Holding ELDN

About Eledon Pharmaceuticals, Inc.


  • Ticker ELDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,756,800
  • Market Cap $72.9M
  • Description
  • Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...
More about ELDN
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.